Effects of high fat feeding on adipose tissue gene expression in diabetic goto-kakizaki rats

Gene Regulation and Systems Biology

Volumn 9, Issue , 2015, Pages 15-26

  Xue, Bai ^a   Nie, Jing ^a   Wang, Xi ^a   DuBois, DeBra C ^a   Jusko, William J ^a   Almon, Richard R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Diabetes; Gene expression; High fat diet; Microarray

Indexed keywords

ABC TRANSPORTER A1; ADIPONECTIN; CXCL14 CHEMOKINE; FATTY ACID SYNTHASE; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; INSULIN; LEPTIN; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA2;

ABAC1 GENE; ABDOMINAL FAT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD5L GENE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CXCL14 GENE; DISEASE EXACERBATION; ENPP1 GENE; EPHX2 GENE; FABP3 GENE; FAT MASS; FATTY ACID SYNTHESIS; FNIP 1 GENE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GLUCOSE BLOOD LEVEL; GOTO KAKIZAKI RAT; HEMOGLOBIN BLOOD LEVEL; HMGCS GENE; HORMONE BLOOD LEVEL; IMMUNOMODULATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KLF9 GENE; LGAL5 GENE; LIPID DIET; LIPID METABOLISM; LIPOATROPHY; LIPOGENESIS; MALE; MICROARRAY ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLAA GENE; POSTNATAL GROWTH; RAT; STAT 3 GENE; TGF BETA2 GENE; WISTAR KYOTO RAT;

ANIMALIA; RATTUS;

EID: 84939640854     PISSN: None     EISSN: 11776250     Source Type: Journal    
DOI: 10.4137/GRSB.S25172     Document Type: Article

References (60)

1. Nutritional recommendations and principles for individuals with diabetes mellitus: 1986. American Diabetes Association. Diabetes Care. 1987; 10(1): 126-32.
2. Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol. 1986; 251(5 pt 1): E576-83.
3. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. 1988. Nutrition. 1997; 13(1): 65.
4. Reaven GM, Lerner RL, Stern MP, Farquhar JW. Role of insulin in endogenous hypertriglyceridemia. J Clin Invest. 1967; 46(11): 1756-67.
5. Tannenbaum BM, Brindley DN, Tannenbaum GS, Dallman MF, McArthur MD, Meaney MJ. High-fat feeding alters both basal and stress-induced hypothalamic-pituitary-adrenal activity in the rat. Am J Physiol. 1997; 273(6 pt 1): E1168-77.
6. Barnea M, Shamay A, Stark AH, Madar Z. A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression. Obesity. 2006; 14(12): 2145-53.
7. Scarpace PJ, Zhang Y. Leptin resistance: a prediposing factor for diet-induced obesity. Am J Physiol Regul Integr Comp Physiol. 2009; 296(3): R493-500.
8. Van Heek M, Compton DS, France CF, et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest. 1997; 99(3): 385-90.
9. Keller MP, Attie AD. Physiological insights gained from gene expression analysis in obesity and diabetes. Annu Rev Nutr. 2010; 30: 341-64.
10. Moraes RC, Blondet A, Birkenkamp-Demtroeder K, et al. Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses. Endocrinology. 2003; 144(11): 4773-82.
11. Bunger M, Hooiveld GJ, Kersten S, Muller M. Exploration of PPAR functions by microarray technology-a paradigm for nutrigenomics. Biochim Biophys Acta. 2007; 1771(8): 1046-64.
12. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science. 2001; 294(5548): 1866-70.
13. Christodoulides C, Lagathu C, Sethi JK, Vidal-Puig A. Adipogenesis and WNT signalling. Trends Endocrinol Metab. 2009; 20(1): 16-24.
14. Engeli S, Janke J, Gorzelniak K, et al. Regulation of the nitric oxide system in human adipose tissue. J Lipid Res. 2004; 45(9): 1640-8.
15. Goto Y, Suzuki K, Ono T, Sasaki M, Toyota T. Development of diabetes in the non-obese NIDDM rat (GK rat). Adv Exp Med Biol. 1988; 246: 29-31.
16. Portha B. Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Diabetes Metab Res Rev. 2005; 21(6): 495-504.
17. Xue B, Sukumaran S, Nie J, Jusko WJ, Dubois DC, Almon RR. Adipose tissue deficiency and chronic inflammation in diabetic Goto-Kakizaki rats. PLoS One. 2011; 6(2): e17386.
18. Almon RR, Dubois DC, Sukumaran S, et al. Effects of high fat feeding on liver gene expression in diabetic goto-kakizaki rats. Gene Regul Syst Bio. 2012; 6: 151-68.
19. Almon RR, DuBois DC, Lai W, Xue B, Nie J, Jusko WJ. Gene expression analysis of hepatic roles in cause and development of diabetes in Goto-Kakizaki rats. J Endocrinol. 2009; 200(3): 331-46.
20. Nie J, Xue B, Sukumaran S, Jusko WJ, Dubois DC, Almon RR. Differential muscle gene expression as a function of disease progression in Goto-Kakizaki diabetic rats. Mol Cell Endocrinol. 2011; 338(1-2): 10-7.
21. Ehses JA, Perren A, Eppler E, et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes. 2007; 56(9): 2356-70.
22. Kraakman MJ, Murphy AJ, Jandeleit-Dahm K, Kammoun HL. Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front Immunol. 2014; 5: 470.
23. Navarro E, Funtikova AN, Fito M, Schroder H. Can metabolically healthy obesity be explained by diet, genetics, and inflammation? Mol Nutr Food Res. 2015; 59(1): 75-93.
24. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006; 116(7): 1793-801.
25. Brunetti P. The lean patient with type 2 diabetes: characteristics and therapy challenge. Int J Clin Pract. 2007; 153: 3-9.
26. Tirone TA, Brunicardi FC. Overview of glucose regulation. World J Surg. 2001; 25(4): 461-7.
27. Barbu A, Hedlund GP, Lind J, Carlsson C. Pref-1 and adipokine expression in adipose tissues of GK and Zucker rats. Mol Cell Endocrinol. 2009; 299(2): 163-71.
28. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. 1998; 78(3): 783-809.
29. Sukumaran S, Xue B, Jusko WJ, Dubois DC, Almon RR. Circadian variations in gene expression in rat abdominal adipose tissue and relationship to physiology. Physiol Genomics. 2010; 42 A(2): 141-52.
30. Swarbrick MM, Havel PJ. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord. 2008; 6(2): 87-102.
31. Arch JR. Central regulation of energy balance: inputs, outputs and leptin resistance. Proc Nutr Soc. 2005; 64(1): 39-46.
32. Hackl H, Burkard TR, Sturn A, et al. Molecular processes during fat cell development revealed by gene expression profiling and functional annotation. Genome Biol. 2005; 6(13): R108.
33. Esau C, Kang X, Peralta E, et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem. 2004; 279(50): 52361-5.
34. Ali AT, Hochfeld WE, Myburgh R, Pepper MS. Adipocyte and adipogenesis. Eur J Cell Biol. 2013; 92(6-7): 229-36.
35. Du B, Cawthorn WP, Su A, et al. The transcription factor paired-related homeobox 1 (Prrx1) inhibits adipogenesis by activating transforming growth factor-beta (TGFbeta) signaling. J Biol Chem. 2013; 288(5): 3036-47.
36. Cernkovich ER, Deng J, Bond MC, Combs TP, Harp JB. Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity. Endocrinology. 2008; 149(4): 1581-90.
37. Baba M, Hong SB, Sharma N, et al. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci U S A. 2006; 103(42): 15552-7.
38. Le Lay S, Robichon C, Le Liepvre X, Dagher G, Ferre P, Dugail I. Regulation of ABCA1 expression and cholesterol efflux during adipose differentiation of 3T3-L1 cells. J Lipid Res. 2003; 44(8): 1499-507.
39. Nara N, Nakayama Y, Okamoto S, et al. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance. J Biol Chem. 2007; 282(42): 30794-803.
40. Pei L, Castrillo A, Tontonoz P. Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol Endocrinol. 2006; 20(4): 786-94.
41. Sugerman PB, Faber SB, Willis LM, et al. Kinetics of gene expression in murine cutaneous graft-versus-host disease. Am J Pathol. 2004; 164(6): 2189-202.
42. Soares L, Seroogy C, Skrenta H, et al. Two isoforms of otubain 1 regulate T cell anergy via GRAIL. Nat Immunol. 2004; 5(1): 45-54.
43. Anand PK. Exosomal membrane molecules are potent immune response modulators. Commun Integr Biol. 2010; 3(5): 405-8.
44. Cao Y, Dubois DC, Sun H, Almon RR, Jusko WJ. Modeling diabetes disease progression and salsalate intervention in Goto-Kakizaki rats. J Pharmacol Exp Ther. 2011; 339(3): 896-904.
45. Wang X, DuBois DC, Cao Y, Jusko WJ, Almon RR. Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment. Diabetes Metab Syndr Obes. 2014; 7: 381-9.
46. Bacci S, De Cosmo S, Prudente S, Trischitta V. ENPP1 gene, insulin resistance and related clinical outcomes. Curr Opin Clin Nutr Metab Care. 2007; 10(4): 403-9.
47. Maddux BA, Chang YN, Accili D, McGuinness OP, Youngren JF, Goldfine ID. Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia. Am J Physiol Endocrinol Metab. 2006; 290(4): E746-9.
48. Liang J, Fu M, Ciociola E, Chandalia M, Abate N. Role of ENPP1 on adipocyte maturation. PLoS One. 2007; 2(9): e882.
49. Varma V, Yao-Borengasser A, Bodles AM, et al. Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes. 2008; 57(2): 432-9.
50. Daniel C, Schaub K, Amann K, Lawler J, Hugo C. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo. Diabetes. 2007; 56(12): 2982-9.
51. Tan BK, Adya R, Chen J, et al. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin−1. Cardiovasc Res. 2009; 83(3): 566-74.
52. Berndt J, Kovacs P, Ruschke K, et al. Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia. 2007; 50(7): 1472-80.
53. Wang Y, Jones Voy B, Urs S, et al. The human fatty acid synthase gene and de novo lipogenesis are coordinately regulated in human adipose tissue. J Nutr. 2004; 134(5): 1032-38.
54. Dahlman I, Linder K, Arvidsson Nordström E, et al. Changes in adipose tissue gene expression with energy-restricted diets in obese women. Am J Clin Nutr. 2005; 81(6): 1275-85.
55. Diggle CP, Carr IM, Zitt E, et al. Common and recurrent HPGD mutations in Caucasian individuals with primary hypertrophic osteoarthropathy. Rheumatology. 2010; 49(6): 1056-62.
56. Way JM, Harrington WW, Brown KK, et al. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues. Endocrinology. 2001; 142(3): 1269-77.
57. Wentz AE, d'Avignon DA, Weber ML, et al. Adaptation of myocardial substrate metabolism to a ketogenic nutrient environment. J Biol Chem. 2010; 285(32): 24447-56.
58. Yi W, Fu P, Fan Z, et al. Mitochondrial HMG-CoA synthase partially contributes to antioxidant protection in the kidney of stroke-prone spontaneously hypertensive rats. Nutrition. 2010; 26(11-12): 1176-80.
59. Hageman RS, Wagener A, Hantschel C, Svenson KL, Churchill GA, Brockmann GA. High-fat diet leads to tissue-specific changes reflecting risk factors for diseases in DBA/2J mice. Physiol Genomics. 2010; 42(1): 55-66.
60. Cawthorn WP, Sethi JK. TNF-alpha and adipocyte biology. FEBS Lett. 2008; 582(1): 117-31.